Cargando…

The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis

BACKGROUND: Dysbiotic intestinal and oral microbiota have been implicated in the pathogenesis of rheumatoid arthritis (RA), but the mechanisms how microbiota could impact disease activity have remained elusive. The aim of this study was to assess the association of the biological activity of serum l...

Descripción completa

Detalles Bibliográficos
Autores principales: Parantainen, J., Barreto, G., Koivuniemi, R., Kautiainen, H., Nordström, D., Moilanen, E., Hämäläinen, M., Leirisalo-Repo, M., Nurmi, K., Eklund, K. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677706/
https://www.ncbi.nlm.nih.gov/pubmed/36411473
http://dx.doi.org/10.1186/s13075-022-02946-z
_version_ 1784833863353106432
author Parantainen, J.
Barreto, G.
Koivuniemi, R.
Kautiainen, H.
Nordström, D.
Moilanen, E.
Hämäläinen, M.
Leirisalo-Repo, M.
Nurmi, K.
Eklund, K. K.
author_facet Parantainen, J.
Barreto, G.
Koivuniemi, R.
Kautiainen, H.
Nordström, D.
Moilanen, E.
Hämäläinen, M.
Leirisalo-Repo, M.
Nurmi, K.
Eklund, K. K.
author_sort Parantainen, J.
collection PubMed
description BACKGROUND: Dysbiotic intestinal and oral microbiota have been implicated in the pathogenesis of rheumatoid arthritis (RA), but the mechanisms how microbiota could impact disease activity have remained elusive. The aim of this study was to assess the association of the biological activity of serum lipopolysaccharides (LPS) with disease activity and likelihood of achieving remission in RA patients. METHODS: We measured Toll-like receptor (TLR) 4-stimulating activity of sera of 58 RA patients with a reporter cell line engineered to produce secreted alkaline phosphatase in response to TLR4 stimulation. Levels of LPS-binding protein, CD14, and CD163 were determined by ELISA assays. RESULTS: The patient serum-induced TLR4 activation (biological activity of LPS) was significantly associated with inflammatory parameters and body mass index at baseline and at 12 months and with disease activity (DAS28-CRP, p<0.001) at 12 months. Importantly, baseline LPS bioactivity correlated with disease activity (p=0.031) and, in 28 early RA patients, the likelihood of achieving remission at 12 months (p=0.009). The level of LPS bioactivity was similar at baseline and 12-month visits, suggesting that LPS bioactivity is an independent patient-related factor. Neutralization of LPS in serum by polymyxin B abrogated the TLR4 signaling, suggesting that LPS was the major contributor to TLR4 activation. CONCLUSION: We describe a novel approach to study the biological activity of serum LPS and their impact in diseases. The results suggest that LPS contribute to the inflammatory burden and disease activity on patients with RA and that serum-induced TLR4 activation assays can serve as an independent prognostic factor. GRAPHICAL ABSTRACT: A graphical summary of the conclusions of the study. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-022-02946-z.
format Online
Article
Text
id pubmed-9677706
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96777062022-11-22 The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis Parantainen, J. Barreto, G. Koivuniemi, R. Kautiainen, H. Nordström, D. Moilanen, E. Hämäläinen, M. Leirisalo-Repo, M. Nurmi, K. Eklund, K. K. Arthritis Res Ther Research BACKGROUND: Dysbiotic intestinal and oral microbiota have been implicated in the pathogenesis of rheumatoid arthritis (RA), but the mechanisms how microbiota could impact disease activity have remained elusive. The aim of this study was to assess the association of the biological activity of serum lipopolysaccharides (LPS) with disease activity and likelihood of achieving remission in RA patients. METHODS: We measured Toll-like receptor (TLR) 4-stimulating activity of sera of 58 RA patients with a reporter cell line engineered to produce secreted alkaline phosphatase in response to TLR4 stimulation. Levels of LPS-binding protein, CD14, and CD163 were determined by ELISA assays. RESULTS: The patient serum-induced TLR4 activation (biological activity of LPS) was significantly associated with inflammatory parameters and body mass index at baseline and at 12 months and with disease activity (DAS28-CRP, p<0.001) at 12 months. Importantly, baseline LPS bioactivity correlated with disease activity (p=0.031) and, in 28 early RA patients, the likelihood of achieving remission at 12 months (p=0.009). The level of LPS bioactivity was similar at baseline and 12-month visits, suggesting that LPS bioactivity is an independent patient-related factor. Neutralization of LPS in serum by polymyxin B abrogated the TLR4 signaling, suggesting that LPS was the major contributor to TLR4 activation. CONCLUSION: We describe a novel approach to study the biological activity of serum LPS and their impact in diseases. The results suggest that LPS contribute to the inflammatory burden and disease activity on patients with RA and that serum-induced TLR4 activation assays can serve as an independent prognostic factor. GRAPHICAL ABSTRACT: A graphical summary of the conclusions of the study. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-022-02946-z. BioMed Central 2022-11-21 2022 /pmc/articles/PMC9677706/ /pubmed/36411473 http://dx.doi.org/10.1186/s13075-022-02946-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Parantainen, J.
Barreto, G.
Koivuniemi, R.
Kautiainen, H.
Nordström, D.
Moilanen, E.
Hämäläinen, M.
Leirisalo-Repo, M.
Nurmi, K.
Eklund, K. K.
The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
title The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
title_full The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
title_fullStr The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
title_full_unstemmed The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
title_short The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
title_sort biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677706/
https://www.ncbi.nlm.nih.gov/pubmed/36411473
http://dx.doi.org/10.1186/s13075-022-02946-z
work_keys_str_mv AT parantainenj thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT barretog thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT koivuniemir thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT kautiainenh thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT nordstromd thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT moilanene thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT hamalainenm thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT leirisalorepom thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT nurmik thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT eklundkk thebiologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT parantainenj biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT barretog biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT koivuniemir biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT kautiainenh biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT nordstromd biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT moilanene biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT hamalainenm biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT leirisalorepom biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT nurmik biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis
AT eklundkk biologicalactivityofserumbacteriallipopolysaccharidesassociateswithdiseaseactivityandlikelihoodofachievingremissioninpatientswithrheumatoidarthritis